Stay updated with breaking news from Nasdaq Scps. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Scopus BioPharma Inc. (NASDAQ:SCPS – Get Rating) was the recipient of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 100,000 shares, an increase of 82.5% from the May 15th total of 54,800 shares. Based on an average daily volume of 279,800 shares, the […]
Scopus BioPharma Inc. (NASDAQ:SCPS – Get Rating) was the recipient of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 54,800 shares, a decline of 39.4% from the April 30th total of 90,400 shares. Based on an average daily volume of 296,600 shares, the […]
Raphael (“Rafi”) Hofstein, Ph.D. Brings Invaluable Experience to Scopus BioPharma...
Alan Horsager, Ph.D., President and Chief Executive Officer of Duet, to Present onTLR9 Activation and STAT3 Inhibition: A Bifunctional Approach to...
Company’s Director Nominees are Highly Qualified and Experienced with Track Records of Guiding Early-Stage Life Science Companies Executing Strategy to...